CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 62 enrolled
Drug / intervention
Microalgae Extract Capsules +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06425094
NCT06425094N/ACompleted

Effects of a Microalgae Extract Dietary Supplement on Gut Health, Anxiety, and Immune Function

Colorado State University·interventional·Posted May 22, 2024·Updated Feb 17, 2026

In Brief

A clinical study evaluating Microalgae Extract Capsules and Placebo for Gastrointestinal Problem and 3 related conditions. Completed, enrolled 62 participants across 1 site.

Detailed Summary

This study will be conducted to determine the effect of daily Tetrasol consumption in supporting gut health using assessments of gastrointestinal symptoms (GSRS) and bowel habits (BSS) as primary outcome measures. The investigators also intend to explore fecal and blood biomarkers of intestinal permeability/function, determination of anxiety and stress levels through both validated assessments and saliva and blood biomarkers, establishment of intervention safety and tolerability through comprehensive metabolic panels and overall compliance, explore the effects of the intervention on inflammation and acute stress (Cold Presser Test), blood lipid profiles, and gut microbiota composition as secondary outcomes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsMycrophyt LLC

Timeline

N/ACompletedFinished
202420252026
First PostedMay 22, 2024
Enrollment StartFeb 5, 2024
Primary CompletionMay 24, 2024
Study CompletionJan 31, 2025
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 2.1 years ago

Interventions

Microalgae Extract Capsulesdietary

Tetrasol extract

Placebodietary

maltodextrin \& vegetable magnesium stearate